Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00081) | |||||
---|---|---|---|---|---|
Name |
Bumetanide
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
bumetanide; 28395-03-1; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Burinex; Fordiuran; Lunetoron; Fontego; Segurex; Ro 10-6338; Bumetanida; Bumetanidum; Bumetanidum [INN-Latin]; 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; Bumetanida [INN-Spanish]; PF 1593; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; UNII-0Y2S3XUQ5H; Bumetanide-d5; C17H20N2O5S; 0Y2S3XUQ5H; MLS000028457; CHEBI:3213; Aquazone; Butinat; Cambiex; Diurama; Yurinex; BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-; Burine; 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid; 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid; Lixil-Leo; 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid; MFCD00078949; NCGC00015149-02; SMR000058418; CAS-28395-03-1; Ro 10-6338;PF 1593; DSSTox_CID_2699; 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid; DSSTox_RID_76695; DSSTox_GSID_22699; Bufenox; Bumex (TN); SR-01000003062; EINECS 249-004-6; BRN 2185351; Bumetanide (Ro 10-6338); Prestwick_679; Bumetanide [USAN:USP:INN:BAN:JAN]; Ro-10-6338; Spectrum_001317; Bumetanide, >=98%; Opera_ID_1734; Prestwick0_000276; Prestwick1_000276; Prestwick2_000276; Prestwick3_000276; Spectrum2_001050; Spectrum3_001481; Spectrum4_000030; Spectrum5_001212; Lopac-B-3023; B 3023; cid_2471; CHEMBL1072; Lopac0_000162; SCHEMBL27525; BSPBio_000152; BSPBio_001508; BSPBio_003061; KBioGR_000228; KBioGR_000439; KBioSS_000228; KBioSS_001797; MLS001148265; DivK1c_000034; SPECTRUM1502004; SPBio_000980; SPBio_002371; BPBio1_000168; Bumetanide (JP17/USP/INN); GTPL4837; DTXSID5022699; BDBM25903; HMS500B16; KBio1_000034; KBio2_000228; KBio2_001797; KBio2_002796; KBio2_004365; KBio2_005364; KBio2_006933; KBio3_000455; KBio3_000456; KBio3_002561; NINDS_000034; 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid; Bio1_000421; Bio1_000910; Bio1_001399; Bio2_000228; Bio2_000708; HMS1361L10; HMS1568H14; HMS1791L10; HMS1921B20; HMS1989L10; HMS2089P13; HMS2092N03; HMS2095H14; HMS2230P15; HMS3259O08; HMS3260B05; HMS3374E02; HMS3402L10; HMS3654B13; HMS3712H14; HMS3873C13; Pharmakon1600-01502004; BCP28485; ZINC3813061; Tox21_110088; Tox21_500162; ANW-45473; CCG-40125; NSC758145; AKOS015896600; Tox21_110088_1; AC-8115; CS-1821; DB00887; KS-5211; LP00162; MCULE-6802013568; NC00550; NE48825; NSC-758145; Ro-106338; SDCCGSBI-0050150.P004; IDI1_000034; IDI1_033978; SMP1_000049; NCGC00015149-01; NCGC00015149-03; NCGC00015149-04; NCGC00015149-05; NCGC00015149-06; NCGC00015149-07; NCGC00015149-08; NCGC00015149-09; NCGC00015149-10; NCGC00015149-11; NCGC00015149-12; NCGC00015149-13; NCGC00015149-15; NCGC00015149-16; NCGC00015149-26; NCGC00022072-03; NCGC00022072-04; NCGC00022072-05; NCGC00022072-06; NCGC00022072-07; NCGC00022072-08; NCGC00260847-01; HY-17468; SBI-0050150.P003; AB0012138; AB00052253; EU-0100162; ST51014910; SW196834-3; D00247; J10080; 3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid; AB00052253-15; AB00052253-16; AB00052253_17; AB00052253_18; 3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid; 3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid; 395B031; A819434; Q275926; S95008.; J-017055; S-95008.; SR-01000003062-2; SR-01000003062-4; SR-01000003062-7; BRD-K38197229-001-06-7; BRD-K38197229-001-17-4; Z1550648769; Bumetanide, British Pharmacopoeia (BP) Reference Standard; Bumetanide, European Pharmacopoeia (EP) Reference Standard; Bumetanide, United States Pharmacopeia (USP) Reference Standard; Ro 10-6338; PF 1593 pound>>Ro-10-6338; PF1593 pound>>Ro10-6338; PF-1593
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Congestive heart failure | ICD-11: BD10 | [1] | ||
PubChem CID | |||||
Formula |
C17H20N2O5S
|
||||
Canonical SMILES |
CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
|
||||
InChI |
1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)
|
||||
InChIKey |
MAEIEVLCKWDQJH-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2471"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 364.4 | Topological Polar Surface Area | 127 | |
XlogP | 2.8 | Complexity | 528 | ||
Heavy Atom Count | 25 | Rotatable Bond Count | 8 | ||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Bumetanide 0.5 mg tablet | Click to Show/Hide the Full List of Formulation(s): 4 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Eon Labs; Mylan Pharamceuticals; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Talc; Aluminum oxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AvKARE; Carilion Materials Management; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Talc; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Edenbridge Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Bumetanide 1 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Aluminum oxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aidarex Pharmaceuticals; AvKARE; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products; NCS HealthCare of KY, Inc dba Vangard Labs; NuCare Pharmaceuticals; St Marys Medical Park Pharmacy; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | NuCare Pharmaceuticals; Paragon Enterprises | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Aluminum oxide; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Edenbridge Pharmaceuticals; Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aphena Pharma Solutions-Tennessee; Avera McKennan Hospital; Cardinal Health; Carilion Materials Management; Eon Labs; Mylan Pharamceuticals; Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; D&c yellow no. 10; Magnesium stearate; Talc; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack; Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Bumetanide 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 7 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Aphena Pharma Solutions-Tennessee; Avera McKennan Hospital; Eon Labs; NuCare Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Cellulose, microcrystalline; Starch, corn; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Talc; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AvKARE; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products; NCS HealthCare of KY, Inc dba Vangard Labs; St Marys Medical Park Pharmacy; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Ferric oxide red; Talc; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Bryant Ranch Prepack; Edenbridge Pharmaceuticals; Unit Dose Services | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Amneal Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.